Radiopharmaceuticals are drugs that contain radioisotopes used for diagnostic and therapeutic purposes. There are evidences that medicinal herbs and their constituents can modify the radiolabeling, biodistribution, and pharmacokinetics of radiopharmaceuticals through drug interaction. To have an overview of the effects and the underlying mechanisms of medicinal plants on the radiolabeling and bioavailability of radiopharmaceuticals, we conducted this study to summarize the current findings in this field. The scientific literature was systematically collected from databases and analyzed. Studies showed that medicinal plants and their constituents can alter radiolabeling and biodistribution via several mechanisms. Interactions with proteins in red blood cells at the same sites, chelating action of stannous and pertechnetate ions, antioxidant action impeding or decreasing stannous ion oxidation, direct oxidation of stannous ions, generation of reactive oxygen species (ROS) which oxidize stannous ions and damage induced in the cell membrane. Most the medicinal plants can decrease the radioactivity of radiopharmaceuticals, but some of them like Peumus boldus, Punica granatum, Nectandra membranacea, Mentha crispa, Rosmarinus officinalis and derivatives such as eugenol and epigallocatechin gallate have increasing effects. In addition, altering feature in some of them is tissue dependent.
Introduction
In the traditional medicine, many approaches such as aromatherapy, hypnotherapy, yoga, massage therapy, use of medicinal plants, etc. have been used for diagnosing and treatment of patients (1) (2) (3) (4) (5) (6) (7) . These approaches are more safe than the methods that have been used in modern medicine. Medicinal plants are one of most commonly used approaches for treatment of diseases that their effects have been indicated in the various studies (8) (9) (10) (11) (12) (13) (14) . Although medicinal plants can be effective, inexpensive, and efficient treatments for various disorders and frequently used by human beings (15) (16) (17) (18) (19) (20) (21) (22) , sometimes the biological effects of these natural medicines are not fully known. For example, several studies showed that the biodistribution, radiolabeling or the pharmacokinetics of radiopharmaceuticals can be modified by some medicinal plants (23) (24) (25) (26) (27) . If drug interactions on biodistribution and labeling are not addressed, poor image quality and misvisualization in nuclear medicine tests could lead to misdiagnosis with a possible need to repeat the test, therefore so increasing the radiation complication to the patient and the staff. Consequently this problem cause mistreatment in the patients (28) .
Radiopharmaceuticals are applied for drugs labeled with radioactive tracers for therapeutic or diagnostic purposes in medicine. Radioactive labels are radioactive compounds in which one or more atoms have been replaced by a radionuclide so by virtue of its radioactive decay and they used for direct cell labeling. Radioisotopes such as carbon, phosphorus, hydrogen, sulfur, and iodine have been applied widespread to trace the path of biochemical reactions (29). Radioactive tracers are used for diagnostic procedures and can be used in a number of tests. For example, technetium-99m (99mTc), in autoradiography and nuclear medicine, including positron emission tomography (PET), single photon emission computed tomography (SPECT) and scintigraphy (30). In addition, radioactive tracers are used to track the distribution of substances within a cell or tissue (31,32). Radiopharmaceuticals have a wide range application in diagnostic nuclear medicine procedures such as lung perfusion and ventilation, brain blood flow, thyroid scan and thyroid uptake, bone, liver, brain scan, hepatobiliary, pancreas, and kidney scans, bone marrow, cardiac imaging procedures, localization of gastrointestinal bleeding, tumor localization studies, and nonimaging studies of blood volume and iron metabolism (33). The radiolabeling of blood constituents is widely used and has great importance in nuclear medicine for both diagnostic imaging and targeted radionuclide therapy (34). Several studies have suggested that radiolabeling of blood constituents with radiopharmaceuticals could be performed to evaluate the biological effects of medicinal plant extracts (23, 35, 36) . Besides, some the synthetic drugs and medicinal herbs can alter the biodistribution of radiopharmaceutical and the analysis of scintigraphic images and physicians must be cautious about this problem (24, 37) . Hence, this study was conducted to review the effects and mechanisms of medicinal plants, their derivatives and compounds on radiolabeling and bioavailability of diagnostic radiopharmaceuticals.
Search strategies
The words radiopharmaceutical, alongside with, radiolabeling, biodistribution and bioavailability in combination with some herbal terms such as medicinal plant, phyto* and herb* were used to search for relevant publications indexed in the Institute for Scientific Information (ISI) and PubMed.
A standard form was designed, which included items such as the aim or the title of the study, intervention, outcome, variables, journal name, period, and number. The article's contents that were relevant to this study were recorded on the form and entered into the study upon agreement of the researchers involved in this study. Then the plants and the plant-based products that were reported to be effective in labeling and distribution of diagnostic radiopharmaceuticals were selected. The articles whose full texts were not accessible, studies with neutral effects, non-English language articles, review articles, and studies that were not related to the purpose of this study were excluded after all researchers in this study agreement was achieved. Fig. 1 illustrates how the articles were selected for final analysis. 
Results
The previous studies indicated that that medicinal plants and their derivates can alter radiolabeling and biodistribution. Most the medicinal plants could decrease the radioactivity of radiopharmaceuticals, but some of plants such as Peumus boldus, Punica granatum, Nectandra membranacea, Mentha crispa, Rosmarinus officinalis have increasing effects ( Table 1 ).
In addition, there are some phytochemicals and herbal combinations that affect radiolabeling and biodistribution of radiopharmaceuticals ( Table 2) .
Several factors that categorized in physical and chemical factors may affect drug delivery and the radiolabeling of a chemical compound (65) (66) (67) (68) . For instance, pharmaceutical variables, such as sedimentation problems or instability of the cell chelator, choice of anticoagulant, level of stannous ion and oxidation of radiopharmaceuticals, difficulties with collecting sufficient cells, or problems may arise which are patient-related (drug interference or the presence of disease) can affect the radiolabeling and misdistribution of radiopharmaceuticals (69) . Medicinal herbs and constituents can reduce the labeling and distribution of diagnostic radiopharmaceuticals in several ways ( Fig. 2) . Interactions with the blood constituents protein at same sites of radiopharmaceuticals binding and disrupted the radiolabeling efficiency. The other way is direct inhibition (chelating action) of the stannous and pertechnetate ions (23) . Because chelator activity has an important pharmacokinetic role in the development of labeling and bioavailability of radiopharmaceuticals targeting (70) . Both the antioxidant and oxidant agents (or generation them in chemical interaction) in medicinal plants, in turn, can reduce the cell's labeling. Direct oxidation with the presence of oxidant agents or generation of free radicals that could oxidize the stannous ion (62) . In addition, medicinal plants have polyphenols that are micronutrients with antioxidant activity. On the other hand, RBC labeling procedure with radiopharmaceuticals such as 99 mTc depends on the presence of stannous (+2) ions (40). Antioxidant property of medicinal plants can block the action of stannous ions, antioxidant action impeding or decreasing the stannous ion oxidization and binding to them in labeling and fixation procedure; so decreasing the binding of radiopharmaceuticals in plasma proteins (23, 71) . The last way is an alteration of the plasma membrane structure and receptors or changing in the transport systems of stannous and pertechnetate ions into cells. So, they alter the transport of ions (stannous and pertechnetate ions) through the cellular membrane (23, 58) . Pertechnetate anions across membranes of human blood constituents have a vital role in radiolabeling.
The pertechnetate anion may reach the interior of the blood cells constituents (stannous and pertechnetate ions pass through the membrane) via the band-3 anion transport system (72) . In other words, medicinal plants and their derivatives act in the transport of the pertechnetate ion via the cellular membrane of determined organs (73) . The herbs chemical compounds can alter the blood cells membrane morphology (59) , and it is one of the altering mechanisms of radiopharmaceutical labeling on the cells. Another result of this study suggests that the medicinal herbs and their components can act on the biodistribution of radiopharmaceuticals in specific organs (28) .
In this regards, radiolabeling and biodistribution also depend on the type of tissue (64) . This can be due to differences in receptors in various body tissues. Although, some of the medicinal herbs didn't has an effect on radiolabeling of radiopharmaceuticals. Because labeling depends on the presence of reducing agent or chemical substances, so without such interfering substances, they can't interaction with the radiolabeling process (59, 74) .
Therefore, precaution must be considered in the interpretation of diagnostic radiopharmaceuticals results when patients are concomitant using these drugs and must be cautious about misdiagnosis and/or repetition of the examinations in nuclear medicine.
Although these results mainly were obtained with animal studies, caution must be considered in the interaction of the nuclear examination when the patient is using these medicinal herbs. So limitation in human studies was a weakness of the reviewed articles which can disturb generalizability of the study's results to the human population.
Conclusion
Studies showed that medicinal plants and constituents can alter radiolabeling and biodistribution via several mechanisms. They can interactions with the blood cells compartment proteins at same sites, chelating action on the stannous and pertechnetate ions, antioxidant action impeding or decreasing the stannous ion oxidization, direct oxidation of the stannous ions, generation of reactive oxygen species in the body that could oxidize the stannous ions and damage induced in the cell membrane. Limitation in human studies was a weakness of the reviewed articles which can disturb generalizability of the study's results to the human population. Most of them have decreasing in the radioactivity of radio pharmaceuticals, but some of them have increasing effects. In addition, altering feature in some of them is tissue dependent. Decreasing in the uptake of radioactivity by the RBC in insoluble fractions plasma (IF-P) and in insoluble fractions blood cell (IF-BC) and also alterations in the shape of RBC was observed. 
Increase in the percentage of ATI in lungs, brain, spleen, heart, liver, stout bowel, stomach, muscle, femur, kidneys, pancreas, and testis through the generation of active metabolites.
Infusion Experimental (in vitro)
Punica granatum Amorim et al. (44) Decreasing the radiolabeling of BC via antioxidant action and alters the membrane structures involved in ion transport into cells. Aqueous extract Experimental (in vitro) Psidium guajava Abreu et al. (23) Increase in the percentage of ATI of 99 mTc by muscle, thyroid, heart, kidney and thyroid (%ATI/gram of tissue). So the extract could generate active metabolites able to influence the bioavailability of 99 mTc.
Aqueous extract Experimental (in vitro)
Nectandra membranacea Farias et al. (45) Decreasing the uptake of the Na 99m TcO 4 in the duodenum. This may be due to scavengers of free radicals and chelating agents in the extract. 
Decreasing in the percentage of ATI/g of tissues from duodenum, spleen, pancreas, and blood and increasing in stomach tissue. The extract does not alter the labeling of blood constituents.
Solution
Experimental (in vivo and in vitro) Passiflora edulis Rebello et al.
Reducing %ATI/g of the Na 99m TcO 4 in the thyroid, liver, pancreas, lungs and blood. The extract did not modify the radiolabeling of the blood constituents.
Aqueous extract Experimental (in vivo and in vitro)
Cassia angustifolia Souza et al. 
The extract causes radioiodinated with 131 I, which is a convenient radioisotope for therapy and potential for therapy and imaging due to its notable uptake. 
Iodine

